Bioinformatics Advance Access first published online on June 6, 2007
This version published online on June 14, 2007
Bioinformatics, doi:10.1093/bioinformatics/btm310
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significance Analysis of Groups of Genes in Expression Profiling Studies
1Division of Biometry and Risk Assessment, 2Division of Genetic and Reproductive Toxicology, National Center for Toxicological Research, FDA, Jefferson, AR 72079, USA, 3Institute of Statistical Science, Academia Sinica, Taipei, Taiwan, 4Biostatistics Center, China Medical University, Taichung, Taiwan.
*To whom correspondence should be addressed. Dr. James Chen, E-mail: jchen{at}nctr.fda.gov
 |
Abstract |
|---|
Motivation: Gene class testing (GCT) is a statistical approach to determine whether some functionally predefined classes of genes express differently under two experimental conditions. GCT computes the p-value of each gene class based on the null distribution and the gene classes are ranked for importance in accordance with their p-values. Currently, two null hypotheses have been considered: the Q1 hypothesis tests the relative strength of association with the phenotypes among the gene classes, and the Q2 hypothesis assesses the statistical significance. These two hypotheses are related but not equivalent.
Method: We investigate three one-sided and two two-sided test statistics under Q1 and Q2. The null distributions of gene classes under Q1 are generated by permuting gene labels and the null distributions under Q2 are generated by permuting samples.
Results: We applied the five statistics to a diabetes dataset with 143 gene classes and to a breast cancer data set with 508 GO terms. In each statistic, the null distributions of the gene classes under Q1 are different from those under Q2 in both datasets, and their rankings can be different too. We clarify the one-sided and two-sided hypotheses, and discuss some issues regarding the Q1 and Q2 hypotheses for gene class ranking in the GCT. Because Q1 does not deal with correlations among genes, we prefer test based on Q2.
Associate Editor: Prof. Martin Bishop
The views presented in this article do not necessarily reflect those of the U.S. Food and Drug Administration.
Received on May 9, 2007; revised on May 9, 2007; accepted on June 1, 2007
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-A. Tsai and J. J. Chen Multivariate analysis of variance test for gene set analysis Bioinformatics, April 1, 2009; 25(7): 897 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Dinu, J. D. Potter, T. Mueller, Q. Liu, A. J. Adewale, G. S. Jhangri, G. Einecke, K. S. Famulski, P. Halloran, and Y. Yasui Gene-set analysis and reduction Brief Bioinform, January 1, 2009; 10(1): 24 - 34. [Abstract] [Full Text] [PDF]
|
|